(Q48574868)

12 February 2018

title

Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. (English)

1 reference

12 February 2018

0 references

5

1 reference

12 February 2018

author name string

Ertel W

1

1 reference

12 February 2018

Keel M

2

1 reference

12 February 2018

Stocker R

3

1 reference

12 February 2018

Imhof HG

4

1 reference

12 February 2018

Steckholzer U

6

1 reference

12 February 2018

Tanaka M

7

1 reference

12 February 2018

Trentz O

8

1 reference

12 February 2018

Nagata S

9

1 reference

12 February 2018

publication date

1 December 1997

1 reference

12 February 2018

Journal of Neuroimmunology

published in

1 reference

12 February 2018

volume

80

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

93-96

1 reference

12 February 2018

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Comparison of mortality, morbidity, and severity of 59,713 head injured patients with 114,447 patients with extracranial injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Fas antigen mRNA induction in postischemic murine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

1 reference

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900139-2

7 January 2021

10.1016/S0165-5728(97)00139-2

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9413263

1 reference

12 February 2018